SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is experiencing heavy selling, with widespread community sentiment labeling it a "rugpull" and "scam" amidst a significant market downturn. Many investors are openly criticizing its founder, Charles Hoskinson, and questioning ADA's long-term viability, suggesting a rotation into AI stocks or other cryptocurrencies. While some contrarian investors view current lows as a deep buying opportunity, the dominant discourse reflects strong bearish sentiment across the broader crypto market.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Cisco Systems is trending as its latest earnings report showcased robust growth, particularly in networking revenue driven by surging AI infrastructure orders, leading the stock to reach multi-decade highs not seen since the dot-com era. The community is actively discussing Cisco's role as an "AI Plumbing Powerhouse" through strategic partnerships and solutions, while also debating if the current AI-fueled rally mirrors the dynamics of past market booms.

Sunrun, Inc. engages in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems. It sells solar service offerings and installs solar energy systems for homeowners. Customers can access its products through three channels: direct-to-consumer, solar partnerships, and strategic partnerships. The company was founded by Edward Harris Fenster, Robert Nat Kreamer, and Lynn Michelle Jurich in January 2007 and is headquartered in San Francisco, CA.

Sunrun Inc

Sunrun is trending following a wave of bullish analyst upgrades and the growing market narrative around solar and energy storage's critical role in powering AI data centers. The community is actively discussing the company's strong virtual power plant strategy and consistent cash generation as key drivers. This momentum comes despite broader market volatility and seasonal concerns often associated with the residential solar sector.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

The XRP community is currently polarized during the holiday season, with many lamenting a perceived "Christmas dump" and calling the asset a "scam" or "trash." Despite this strong bearish sentiment and accusations of market manipulation by "whales," a dedicated group of "hodlers" remains optimistic, citing XRP's fundamental utility in cross-border payments and continued institutional interest as reasons for an eventual, significant price increase.

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Redwood City, CA.

Corcept Therapeutics Inc

Corcept Therapeutics (CORT) is trending due to overwhelming positive Phase 3 data for its ovarian cancer drug, relacorilant, which demonstrated improved survival and is touted as a potential new standard of care. This breakthrough has fueled speculation of a significant short squeeze, with community discussion highlighting the drug's blockbuster potential across cancer types and anticipating an upcoming regulatory decision for relacorilant in Cushing's syndrome. The strong pipeline progress is shifting the narrative around CORT as a leader in cortisol modulation, extending beyond its existing market to address major unmet medical needs.

EQT Corp. is a natural gas production company, which engages in the provision of supply, transmission, and distribution of natural gas. The company was founded in 1888 and is headquartered in Pittsburgh, PA.

EQT Corp

EQT is a prominent topic as the natural gas sector anticipates surging demand from increasing LNG exports and significant deals to power AI data centers, particularly given Europe's move to reduce Russian gas reliance. The community is buzzing about EQT's strategic long-term LNG agreements, robust operational performance, and a slew of analyst upgrades, positioning it as a key beneficiary in evolving global energy markets.

Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.

Immuneering Corp - Ordinary Shares Class A

Immuneering Corp

Immuneering (IMRX) is drawing significant investor attention ahead of a critical upcoming data release for its atebimetinib Phase 2a pancreatic cancer trial, building on previously encouraging survival results. The community is actively debating the stock's potential, with many anticipating substantial upside from recent institutional accumulation and insider buying, while others express caution regarding competition and past price volatility. This biotech, recently added to the Nasdaq Biotechnology Index, is viewed by proponents as undervalued, offering a unique therapeutic approach for a challenging cancer with a potential multi-billion dollar market opportunity.

NeOnc Technologies Holdings, Inc. is a clinical-stage biopharmaceutical company. It develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company was founded in 2008 and is headquartered in Calabasas, CA.

NeOnc Technologies Holdings Inc.

NeOnc Technologies is trending due to highly encouraging updated clinical data for its NEO100 brain cancer therapy, which observers are calling a potential paradigm shift in a hard-to-treat disease. This positive momentum is bolstered by a significant $50 million strategic partnership for international expansion and funding, creating considerable excitement among investors regarding the company's innovative CNS oncology pipeline.

Stellus Capital Investment Corp, a traded fund, invests in companies located in the United States with an EBITDA of USD 5 - 50 million. The fund focuses on a broad range of sectors and industries. It provides financing in the form of equity, senior secured first lien, uni tranche, split lien and second lien debt financings for buyout transactions with an investment size of USD 10 - 75 million.

Stellus Capital Investment Corp

Stellus Capital Investment Corporation

Stellus Capital Investment is trending amidst strong quarterly earnings beats and a highly anticipated shift in monetary policy, with the community actively discussing multiple analyst upgrades and the potential for significant interest rate cuts. Investors are highlighting SCM's consistent dividend, robust balance sheet, and perceived undervaluation, especially as macro-economic factors align positively for BDCs, drawing institutional interest and expectations for continued growth.

East West Bancorp, Inc. is a bank holding company, which engages in the provision of financial services. It operates through the following business segments: Consumer and Business Banking, Commercial Banking, and Other. The Consumer and Business Banking segment provides financial service products and services to consumer and commercial customers through the company's branch network in the U.S. The Commercial Banking segment primarily focuses on commercial loans and deposits. The Other segment includes treasury activities of the company and elimination of inter-segment amounts. The company was founded on August 26, 1998 and is headquartered in Pasadena, CA.

East West Bancorp, Inc.

East West Bancorp is trending due to its consistent earnings beats, which have fueled numerous analyst upgrades and positive price target revisions. The community is actively discussing its strong long-term growth potential, especially as analysts anticipate a breakout year for the broader banking sector with favorable macro tailwinds. Despite some technical indicators suggesting overbought conditions, the prevailing sentiment remains bullish, highlighting its leadership among regional banks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


banghieuviet

BangHieuViet